The chain of evidence supporting this conclusion consisted first of the fact that gankyrin expression is correlated with the expression of immune cell-derived pro-inflammatory IL-17-related cytokines and with that of stem cell marker (Lgr5) in the colonic mucosa of IBD patients. The gene discussed is LGR5; the disease is inflammatory bowel disease.